Circulating Th22 and Th9 levels in patients with acute coronary syndrome

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Lin, Ying Zhong ^a   Wu, Bang Wei ^b   Lu, Zheng De ^a   Huang, Ying ^a   Shi, Ying ^a   Liu, Hao ^a   Liu, Ling ^a   Zeng, Qiu Tang ^b   Wang, Xiang ^b   Ji, Qing Wei ^a  

^a PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN A; APOLIPOPROTEIN B; AROMATIC HYDROCARBON RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 22; INTERLEUKIN 9; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; TRANSCRIPTION FACTOR PU 1; TRIACYLGLYCEROL; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENSINI SCORE; GLUCOSE BLOOD LEVEL; HELPER CELL; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; TH22 CELL; TH9 CELL; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS; AGED; BLOOD; HEART LEFT VENTRICLE FUNCTION; IMMUNOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACUTE CORONARY SYNDROME; AGED; ANGINA, STABLE; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-9; INTERLEUKINS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RECEPTORS, ARYL HYDROCARBON; T-LYMPHOCYTES, HELPER-INDUCER; TRANS-ACTIVATORS; VENTRICULAR FUNCTION, LEFT;

EID: 84896380560     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/635672     Document Type: Article

References (47)

1. Hansson G. K., Hermansson A., The immune system in atherosclerosis. Nature Immunology 2011 12 3 204 212 2-s2.0-79951669207 10.1038/ni.2001
2. Lahoute C., Herbin O., Mallat Z., Tedgui A., Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nature Reviews Cardiology 2011 8 6 348 358 2-s2.0-79957836641 10.1038/nrcardio.2011.62
3. Weyand C. M., Goronzy J. J., Liuzzo G., Kopecky S. L., Holmes D. R. Jr., T-cell immunity in acute coronary syndromes. Mayo Clinic Proceedings 2001 76 10 1011 1020 10.4065/76.10.1011 (Pubitemid 32946013)
4. Robertson A.-K. L., Hansson G. K., T cells in atherogenesis: for better or for worse? Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 11 2421 2432 2-s2.0-33750203252 10.1161/01.ATV.0000245830.29764.84 (Pubitemid 44607461)
5. Frostegard J., Ulfgren A. K., Nyberg P., Hedin U., Swedenborg J., Andersson U., Hansson G. K., Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999 145 1 33 43 (Pubitemid 29292698)
6. Yilmaz A., Lochno M., Traeg F., Cicha I., Reiss C., Stumpf C., Raaz D., Anger T., Amann K., Probst T., Ludwig J., Daniel W. G., Garlichs C. D., Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004 176 1 101 110 (Pubitemid 39078651)
7. Methe H., Brunner S., Wiegand D., Nabauer M., Koglin J., Edelman E. R., Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. Journal of the American College of Cardiology 2005 45 12 1939 1945 10.1016/j.jacc.2005.03.040 (Pubitemid 40814112)
8. -/-) mice through modulation of Th1/Th2 balance. Journal of Molecular and Cellular Cardiology 2008 45 2 168 175
9. -/- mice. American Journal of Pathology 2000 157 6 1819 1824 2-s2.0-0033635218
10. Eid R. E., Rao D. A., Zhou J., Lo S. F., Ranjbaran H., Gallo A., Sokol S. I., Pfau S., Pober J. S., Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009 119 10 1424 1432
11. Erbel C., Chen L., Bea F., Wangler S., Celik S., Lasitschka F., Wang Y., Bockler D., Katus H. A., Dengler T. J., Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. The Journal of Immunology 2009 183 12 8167 8175 10.4049/jimmunol.0901126
12. Smith E., Prasad K. M., Butcher M., Dobrian A., Kolls J. K., Ley K., Galkina E., Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010 121 15 1746 1755 10.1161/CIRCULATIONAHA.109.924886
13. Danzaki K., Matsui Y., Ikesue M., Ohta D., Ito K., Kanayama M., Kurotaki D., Morimoto J., Iwakura Y., Yagita H., Tsutsui H., Uede T., Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 2 273 280 10.1161/ATVBAHA.111.229997
14. Butcher M. J., Gjurich B. N., Phillips T., Galkina E. V., The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment. Circulation Research 2012 110 5 675 687 2-s2.0-84857922610 10.1161/CIRCRESAHA.111.261784
15. Usui F., Kimura H., Ohshiro T., Tatsumi K., Kawashima A., Nishiyama A., Iwakura Y., Ishibashi S., Takahashi M., Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice. Biochemical and Biophysical Research Communications 2012 420 1 72 77
16. Madhur M. S., Funt S. A., Li L., Vinh A., Chen W., Lob H. E., Iwakura Y., Blinder Y., Rahman A., Quyyumi A. A., Harrison D. G., Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 7 1565 1572 10.1161/ATVBAHA.111.227629
17. Ait-Oufella H., Salomon B. L., Potteaux S., Robertson A. K., Gourdy P., Zoll J., Merval R., Esposito B., Cohen J. L., Fisson S., Flavell R. A., Hansson G. K., Klatzmann D., Tedgui A., Mallat Z., Natural regulatory T cells control the development of atherosclerosis in mice. Nature Medicine 2006 12 2 178 180 10.1038/nm1343 (Pubitemid 43214743)
18. + regulatory T cells in experimental atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 4 893 900 10.1161/01.ATV.0000259365.31469.89 (Pubitemid 46606722)
19. -/- mice. Journal of Clinical Immunology 2012 32 5 1104 1117 10.1007/s10875-012-9699-7
20. Mallat Z., Gojova A., Brun V., Esposito B., Fournier N., Cottrez F., Tedgui A., Groux H., Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003 108 10 1232 1237 10.1161/01.CIR.0000089083.61317.A1 (Pubitemid 37099993)
21. Ji Q. W., Guo M., Zheng J. S., Mao X. B., Peng Y. D., Li S. N., Liang Z. S., Dai Z. Y., Mao Y., Zeng Q. T., Downregulation of T helper cell type 3 in patients with acute coronary syndrome. Archives of Medical Research 2009 40 4 285 293 10.1016/j.arcmed.2009.04.002
22. Dardalhon V., Awasthi A., Kwon H., Galileos G., Gao W., Sobel R. A., Mitsdoerffer M., Strom T. B., Elyaman W., Ho I. C., Khoury S., Oukka M., Kuchroo V. K., IL-4 inhibits TGF-beta-induced Foxp3+ T cells and together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nature Immunology 2008 9 12 1347 1355
23. Veldhoen M., Uyttenhove C., van Snick J., Helmby H., Westendorf A., Buer J., Martin B., Wilhelm C., Stockinger B., Transforming growth factor-beta "reprograms" the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nature Immunology 2008 9 12 1341 1346
24. Trifari S., Kaplan C. D., Tran E. H., Crellin N. K., Spits H., Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells. Nature Immunology 2009 10 8 864 871 2-s2.0-67651171182 10.1038/ni.1770
25. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F., Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nature Immunology 2009 10 8 857 863 2-s2.0-67651154105 10.1038/ni.1767
26. Basu R., O'Quinn D. B., Silberger D. J., Schoeb T. R., Fouser L., Ouyang W., Hatton R. D., Weaver C. T., Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012 37 6 1061 1075
27. Jäger A., Dardalhon V., Sobel R. A., Bettelli E., Kuchroo V. K., Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. Journal of Immunology 2009 183 11 7169 7177 2-s2.0-73349109145 10.4049/jimmunol.0901906
28. Ye Z. J., Yuan M. L., Zhou Q., Du R. H., Yang W. B., Xiong X. Z., Zhang J. C., Wu C., Qin S. M., Shi H. Z., Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection. PloS ONE 2012 7 2 e31710
29. Truchetet M.-E., Brembilla N. C., Montanari E., Allanore Y., Chizzolini C., Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Research & Therapy 2011 13 5 R166 2-s2.0-80053911955 10.1186/ar3486
30. Zhang L., Li Y. G., Li Y. H., Qi L., Liu X. G., Yuan C. Z., Hu N. W., Ma D. X., Li Z. F., Yang Q., Li W., Li J. M., Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PloS ONE 2012 7 4 e31000
31. Xia Q., Xiang X., Patel S., Puranik R., Xie Q., Bao S., Characterisation of IL-22 and interferon-gamma-inducible chemokines in human carotid plaque. International Journal of Cardiology 2012 154 2 187 189 10.1016/j.ijcard.2011.10. 093
32. Oliveira R. T., Silva R. M., Teo F. H., Mineiro M. F., Ferreira M. C., Altemani A., Mamoni R. L., Menezes F. H., Blotta M. H., Detection of TCD4+ subsets in human carotid atheroma. Cytokine 2013 62 1 131 140
33. Gregersen I., Skjelland M., Holm S., Holven K. B., Krogh-Sørensen K., Russell D., Askevold E. T., Dahl C. P., Ørn S., Gullestad L., Mollnes T. E., Ueland T., Aukrust P., Halvorsen B., Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis. PLoS ONE 2013 8 8 e72769
34. Chang H., Hanawa H., Liu H., Yoshida T., Hayashi M., Watanabe R., Abe S., Toba K., Yoshida K., Elnaggar R., Minagawa S., Okura Y., Kato K., Kodama M., Maruyama H., Miyazaki J., Aizawa Y., Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. The Journal of Immunology 2006 177 6 3635 3643 (Pubitemid 44359895)
35. Wolk K., Witte E., Witte K., Warszawska K., Sabat R., Biology of interleukin-22. Seminars in Immunopathology 2010 32 1 17 31
36. Geboes L., Dumoutier L., Kelchtermans H., Schurgers E., Mitera T., Renauld J.-C., Matthys P., Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis and Rheumatism 2009 60 2 390 395 2-s2.0-59649086053 10.1002/art.24220
37. Yang X. Y., Wang H. Y., Zhao X. Y., Wang L. J., Lv Q. H., Wang Q. Q., Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus. Journal of Clinical Immunology 2013 33 4 767 774
38. Liu T., Peng L., Yu P., Zhao Y., Shi Y., Mao X., Chen W., Cheng P., Wang T., Chen N., Zhang J., Liu X., Li N., Guo G., Tong W., Zhuang Y., Zou Q., Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer. Journal of Clinical Immunology 2012 32 6 1332 1339
39. Whiting D., Hsieh G., Yun J. J., Banerji A., Yao W., Fishbein M. C., Belperio J., Strieter R. M., Bonavida B., Ardehali A., Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. The Journal of Immunology 2004 172 12 7417 7424 (Pubitemid 38747603)
40. Madamanchi N. R., Li S., Patterson C., Runge M. S., Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 3 321 326 2-s2.0-0035095253 (Pubitemid 32201173)
41. Sprague A. H., Khalil R. A., Inflammatory cytokines in vascular dysfunction and vascular disease. Biochemical Pharmacology 2009 78 6 539 552 2-s2.0-67651146363 10.1016/j.bcp.2009.04.029
42. Tedgui A., Mallat Z., Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiological Reviews 2006 86 2 515 581 2-s2.0-33645891172 10.1152/physrev.00024.2005
43. Chang H. C., Sehra S., Goswami R., Yao W., Yu Q., Stritesky G. L., Jabeen R., McKinley C., Ahyi A. N., Han L., Nguyen E. T., Robertson M. J., Perumal N. B., Tepper R. S., Nutt S. L., Kaplan M. H., The transcription factor PU. 1 is required for the development of IL-9-producing T cells and allergic inflammation. Nature Immunology 2010 11 6 527 534
44. Kaplan M. H., Th9 cells: differentiation and disease. Immunological Reviews 2013 252 1 104 115
45. Li H., Rostami A., IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity. Journal of Neuroimmune Pharmacology 2010 5 2 198 209 2-s2.0-77954564758 10.1007/s11481-009-9186-y
46. Staudt V., Bothur E., Klein M., Lingnau K., Reuter S., Grebe N., Gerlitzki B., Hoffmann M., Ulges A., Taube C., Dehzad N., Becker M., Stassen M., Steinborn A., Lohoff M., Schild H., Schmitt E., Bopp T., Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010 33 2 192 202 10.1016/j.immuni.2010.07.014
47. Lu Y., Hong S., Li H., Park J., Hong B., Wang L., Zheng Y., Liu Z., Xu J., He J., Yang J., Qian J., Yi Q., Th9 cells promote antitumor immune responses in vivo. The Journal of Clinical Investigation 2012 122 11 4160 4171 10.1172/JCI65459